Isaac Yi Kim

4.8k total citations
162 papers, 3.5k citations indexed

About

Isaac Yi Kim is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Isaac Yi Kim has authored 162 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Pulmonary and Respiratory Medicine, 53 papers in Molecular Biology and 38 papers in Surgery. Recurrent topics in Isaac Yi Kim's work include Prostate Cancer Treatment and Research (69 papers), Prostate Cancer Diagnosis and Treatment (63 papers) and TGF-β signaling in diseases (24 papers). Isaac Yi Kim is often cited by papers focused on Prostate Cancer Treatment and Research (69 papers), Prostate Cancer Diagnosis and Treatment (63 papers) and TGF-β signaling in diseases (24 papers). Isaac Yi Kim collaborates with scholars based in United States, South Korea and Japan. Isaac Yi Kim's co-authors include Wun‐Jae Kim, Yun‐Sok Ha, Thomas M. Wheeler, Geun Taek Lee, Seong‐Jin Kim, Dug Keun Lee, Shahrokh F. Shariat, Ronald A. Morton, Seth P. Lerner and Dong Hyeon Lee and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Isaac Yi Kim

156 papers receiving 3.5k citations

Peers

Isaac Yi Kim
Toshiyuki Kamoto Japan
Aria F. Olumi United States
Antti Rannikko Finland
Tanya B. Dorff United States
Antoine Valéri France
Chin‐Chen Pan Taiwan
Mikio Igawa Japan
Juan Moróte Spain
Isabel Heidegger Austria
Arthur T. Porter United States
Toshiyuki Kamoto Japan
Isaac Yi Kim
Citations per year, relative to Isaac Yi Kim Isaac Yi Kim (= 1×) peers Toshiyuki Kamoto

Countries citing papers authored by Isaac Yi Kim

Since Specialization
Citations

This map shows the geographic impact of Isaac Yi Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isaac Yi Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isaac Yi Kim more than expected).

Fields of papers citing papers by Isaac Yi Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isaac Yi Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isaac Yi Kim. The network helps show where Isaac Yi Kim may publish in the future.

Co-authorship network of co-authors of Isaac Yi Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Isaac Yi Kim. A scholar is included among the top collaborators of Isaac Yi Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isaac Yi Kim. Isaac Yi Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sundaresan, Vinaik, James A. Bailey, Paweł Rajwa, et al.. (2024). Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Urologic Oncology Seminars and Original Investigations. 43(3). 193.e19–193.e26. 1 indexed citations
2.
Lokeshwar, Soum D., et al.. (2023). Local Therapeutics for the Treatment of Oligo Metastatic Prostate Cancer. Current Urology Reports. 24(10). 455–461. 1 indexed citations
3.
Srivastava, Arnav, Hiren V. Patel, Gopal N. Gupta, et al.. (2022). Survival of nonseminomatous germ cell tumors in pediatric patients and young adults – A stage group stratified analysis. Urologic Oncology Seminars and Original Investigations. 40(4). 169.e1–169.e12. 2 indexed citations
4.
Patel, Hiren V., Arnav Srivastava, Sinae Kim, et al.. (2022). Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular Cancer. The Journal of Urology. 207(5). 1057–1066. 6 indexed citations
5.
Kim, Isaac Yi, Antonina Mitrofanova, Sukanya Panja, et al.. (2022). Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy. Prostate International. 10(2). 75–79. 8 indexed citations
6.
Singer, Eric A., et al.. (2022). Single-Port Robotic Radical Prostatectomy: Short-Term Outcomes and Learning Curve. Journal of Endourology. 36(10). 1285–1289. 17 indexed citations
7.
Kim, Isaac Yi, Thomas L. Jang, Sinae Kim, et al.. (2021). Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era. Cancer Medicine. 10(22). 7909–7920. 4 indexed citations
8.
Sterling, Joshua, Zorimar Rivera‐Núñez, Hiren V. Patel, et al.. (2020). Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care. Clinical Genitourinary Cancer. 18(6). e643–e650. 7 indexed citations
9.
Tan, Xiang‐Lin, E Jian‐Yu, Yong Lin, et al.. (2020). Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer. Cancer Medicine. 9(7). 2379–2389. 23 indexed citations
10.
Lee, Geun Taek, Jenny Desantis, Kiran Madura, et al.. (2020). Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen Therapy. Molecular Cancer Therapeutics. 20(3). 490–499. 73 indexed citations
11.
Srivastava, Arnav, Zorimar Rivera‐Núñez, Sinae Kim, et al.. (2020). Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer. Cancer. 126(13). 2991–3001. 22 indexed citations
12.
Piao, Xuan‐Mei, Pildu Jeong, Ye‐Hwan Kim, et al.. (2018). Urinary cell‐free microRNA biomarker could discriminate bladder cancer from benign hematuria. International Journal of Cancer. 144(2). 380–388. 39 indexed citations
13.
Parikh, Rahul R., Sinae Kim, Mark N. Stein, et al.. (2017). Trends in active surveillance for very low‐risk prostate cancer: do guidelines influence modern practice?. Cancer Medicine. 6(10). 2410–2418. 20 indexed citations
14.
Bansal, Nitu, Monica Bartucci, Shamila Yusuff, et al.. (2016). BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer. Clinical Cancer Research. 22(24). 6176–6191. 49 indexed citations
15.
Foran, David J., et al.. (2015). Exploring automatic prostate histopathology image gleason grading via local structure modeling. PubMed Central. 2649–2652. 19 indexed citations
16.
Kim, Isaac Yi, et al.. (2015). Pharmacokinetics, pharmacodynamics and clinical efficacy of abiraterone acetate for treating metastatic castration-resistant prostate cancer. Expert Opinion on Drug Metabolism & Toxicology. 11(6). 967–975. 17 indexed citations
17.
18.
Park, Hee Jung, Yun‐Sok Ha, Sung Yul Park, et al.. (2013). Incidence of Upgrading and Upstaging in Patients with Low-Volume Gleason Score 3+4 Prostate Cancers at Biopsy: Finding a New Group Eligible for Active Surveillance. Urologia Internationalis. 90(3). 301–305. 16 indexed citations
19.
Hong, Jun Hyuk, Geun Taek Lee, Jae Ho Lee, et al.. (2008). Effect of bone morphogenetic protein‐6 on macrophages. Immunology. 128(1pt2). e442–50. 63 indexed citations
20.
Lee, Dong Hyeon, Seung Choul Yang, Sung Joon Hong, Byung Ha Chung, & Isaac Yi Kim. (1998). Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.. PubMed. 4(3). 535–8. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiyuki Kamoto Breakdown of academic impact, for papers by Aria F. Olumi Breakdown of academic impact, for papers by Antti Rannikko Breakdown of academic impact, for papers by Tanya B. Dorff Breakdown of academic impact, for papers by Antoine Valéri Breakdown of academic impact, for papers by Chin‐Chen Pan Breakdown of academic impact, for papers by Mikio Igawa Breakdown of academic impact, for papers by Juan Moróte Breakdown of academic impact, for papers by Isabel Heidegger Breakdown of academic impact, for papers by Arthur T. Porter
Rankless by CCL
2026